oncology

AI, machine learning
By  Tammy Lovell 07:51 am February 16, 2021
Italian startup PatchAi has joined forces with pharma giant Roche to launch a digital solution for patients affected by oncological diseases. PatchAi for Smart Health Companion (SHC) embeds a virtual assistant which engages patients through empathic conversations using artificial intelligence (AI) and machine learning. Following a pilot of the platform in July last year, it is now available to...
Person with white jacket with AllianceRx logo speaks to another
By  Laura Lovett 02:27 pm November 16, 2020
Home-delivery pharmacy AllianceRx Walgreens Prime is jumping into the oncology space with its new clinical assessment feature that lets cancer patients digitally manage their self-administered therapies. Specifically, the new feature lets patients with oncology conditions refill their prescriptions online as opposed to over the phone. The way it works is patients can log in to their account and...
By  Laura Lovett 02:02 pm October 6, 2020
A new oncology treatment company dubbed Spesana is emerging out of stealth mode with a new molecular diagnostic decision support tool. The platform is able to take information from a number of sources and synthesize information for providers. The way it works is Spesana’s tech can collect molecular diagnostic reports and coordinate them with EHRs, prior authorizations, payer processing, approved...
By  Dave Muoio 11:49 am August 24, 2020
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds. The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments. Launched in late 2016, One Drop's wireless blood...
By  Dean Koh 04:02 am July 16, 2020
Singapore medical start-up Oncoshot announced that it is partnering with digital healthcare provider MyDoc, to give cancer patients access to second opinion advice from leading oncologists. Founded in 2018, Oncoshot is a collaborative platform for cancer patients and oncologists and according to the start-up, their technology “allows patients to share their data with trial institutes and sponsors...
By  Laura Lovett 11:33 am May 20, 2020
Swedish oncology-focused Elekta has announced its purchase of Kaiku Health, a Helsinki-based startup focused on patient monitoring and patient-reported outcome services. As part of this deal Kaiku Health’s app, which allows patients to track symptoms over time and can alert doctors or researchers with updates, will be integrated into Elekta’s Mosaiq Oncology Information System. “Including...
By  Laura Lovett 02:07 pm April 24, 2020
Computational pathology platform Paige scored an additional $5 million from Goldman Sachs this week, closing its Series B funding at $50 million – exactly double its Series A funding amount. As part of the news, Paige announced that David Castelblanco, managing director at Goldman Sachs, will be joining its board of directors. In December, the company announced its initial $45 million round that...
By  Laura Lovett 03:41 pm January 7, 2020
Oncology management platform OncoLens landed $2.5 million in a Pre-Series A round led by Atlanta Technology Angels and the Robbins Fund yesterday.  This news comes less than a year after the Atlanta-based startup announced a $1.35, which was also led by Atlanta Technology Angles, as well as BIP Capital.  WHAT THEY DO The startup has designed a platform that connects the care teams of patients...
By  Laura Lovett 01:43 pm December 18, 2019
This morning the AI-enabled diagnostic and treatment platform Paige, formerly called Paige.AI, announced a $45 million Series B funding round. The latest raise was led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu and other funders.  Today the company has $70 million in investments. This latest round comes roughly two years after the company closed a $25...
By  Dean Koh 02:14 am November 20, 2019
Singapore-headquartered genomic medicine startup Lucence announced it has raised $20 million in Series A funding. The round was led by IHH Healthcare, one of the world’s largest integrated private healthcare groups, with 80 hospitals in 10 countries worldwide. Other participants include SGInnovate, existing investors Heliconia Capital, a subsidiary of Temasek Holdings, Lim Kaling and Koh Boon...